一株H5亚型禽流感病毒N P蛋白两个鸡M HC分子限制性T细胞表位的鉴定

为验证一株禽流感病毒(AIV)核蛋白(NP)中的3条T细胞表位候选肽NP89-97(PKKTGGPIY)、NP198-206(KRGINDRNF)和NP64-71(ERMVLSAF)的免疫原性,本研究构建了含有NP基因的重组质粒pCAGGS-NP,将其转染293T细胞,间接免疫荧光和western blot检测表明NP蛋白在293T细胞中获得表达.重组质粒免疫鸡后,用间接酶联免疫实验检测发现重组质粒在鸡体内能诱导产生相应的抗体.将多肽NP89-97、NP198-206、NP64-71和不相关肽N71-78(WRRQARYK)在体外刺激免疫后鸡的脾淋巴细胞,流式细胞术检测发现CD8+T淋巴细胞增殖分别为13.7%、11.9%、0.6%和0.4%;ELISA检测结果显示多肽NP89-97、NP198-206刺激后的淋巴细胞中IFN-γ的分泌量明显增加.本实验表明多肽NP89-97和NP198-206能在体外诱导活化的鸡淋巴细胞产生细胞毒性T淋巴细胞反应,为AIV NP的T 细胞表位.该研究结果对研究禽类抗流感病毒的免疫机制及抗流感疫苗具有重要的意义.     

A single amino acid deletion in the antigen binding site of BoLA-DRB3 is predicted to affect peptide binding

Two bovine MHC class II alleles, BoLA-DRB3*0201 and BoLA-DRB3*3301, contain a three base pair deletion which results in the deletion of a lysine (K beta 65) in the antigen recognition site (ARS). Modelling of BoLA-DRB3*0201 with the conserved lysine K beta 65 and BoLA-DRB3*0201 without K beta 65 indicated that this deletion altered the peptide specificity of the ARS, and may impact on the immune response. To test this hypothesis, the presence of K beta 65 was analysed in a sample of cattle vaccinated with the commercial cattle tick vaccine (TickGARD). Homozygous deletion of K beta 65 was significantly associated with high response to TickGARD (P<0.05). Screening of the TickGARD antigen identified a potential T cell epitope that is recognised better by animals that are homozygous for the K beta 65 deletion. This study provides evidence that changes in the ARS of MHC class II molecules may be associated with the well recognised animal to animal variation in magnitude of vaccine response.     

Evaluation of the recognition of Theileria parva vaccine candidate antigens by cytotoxic T lymphocytes from Zebu cattle

East Coast fever (ECF) is a highly fatal lymphoproliferative disease of cattle caused by Theileria parva, a tick-borne intracellular apicomplexan parasite. Parasite antigens that are targets of protective cytotoxic T lymphocyte (CTL) responses are required to formulate a sub-unit vaccine against ECF. A number of CTL target antigens have recently been identified and initial evaluation has shown their vaccine potential. This study aimed to evaluate whether these antigens were recognised by CTL obtained from six genetically diverse Zebu cattle immunized with a cocktail of T. parva stocks. T. parva Muguga specific polyclonal CD8(+) CTL lines were generated and confirmed to specifically lyse autologous infected cells. CTL recognition of autologous skin fibroblasts (iSF) transduced with recombinant modified vaccinia virus Ankara strain (MVA) expressing previously identified T. parva Muguga vaccine candidate antigens was evaluated using an IFN-gamma ELISpot assay. CTL lines from one of the four calves, BY120, responded specifically to cells infected with MVA expressing the antigen Tp2 and synthetic peptides were employed to map a new CTL epitope on this antigen. Immunoscreening of the T. parva genome with these CTL lines should identify novel antigens that will constitute valuable additions to the vaccine candidates currently being evaluated.     

几种圈养珍稀雉鸡H5N1禽流感疫苗免疫后抗体水平研究

家禽对禽流感疫苗免疫效果的研究多有报道,但现有的禽流感疫苗对野生禽类的有效性尚所知甚少。本文以白冠长尾雉、蓝鹇、红腹锦鸡、白腹锦鸡4组野生雉鸡类为研究对象,以家鸡为对照,进行禽流感H5N1亚型疫苗免疫。利用血凝（HA）及血凝抑制（HI）实验,分别在首免日、免后10 d、20 d、40 d、60 d、90 d及120 d监测禽类免疫后抗体水平变化。结果显示,4组野生雉鸡类均在疫苗接种后产生禽流感抗体,且达到具保护力的抗体水平。通过免疫后抗体水平的跟踪研究,证明商品化禽流感疫苗对野生雉鸡类动物有效。     

蓝鹇免疫流感疫苗后抗体消长研究

杭州动物园从北京动物园引进5对蓝鹇种源。日常食物主要是青菜、稻谷、家鸡用颗粒料、少量苹果。饲养过程中发生的主要疾病有细菌性肠炎、发情期的雄性打斗后的外伤等。杭州动物园经过精心饲养,3a繁殖达60多只。蓝鹇在杭州动物园的饲养和繁殖是全国人工饲养繁殖最好,且是全国最大人工种群。由于没有蓝鹇等野禽专用禽流感疫苗,杭州动物园使用家禽禽流感疫苗对蓝鹇进行禽流感免疫。根据家禽的禽流感免疫方法,每年对蓝鹇进行2次禽流感疫苗免疫,由于它的飞翔能力较强,每次免疫进行捕捉时均会乱飞,有时还会造成应激死亡,但最终免疫结果是否有效也未曾进行过检测。本研究中蓝鹇流感疫苗抗体检测采用的方法是：禽流感病毒H5抗体酶联免疫（ELISA）的检测方法。结果证明家禽流感疫苗对蓝鹇有效,经胸部肌肉注射0．5ml／次,每4个月肌注1次,每年免疫3次。雏鹇首免应在出壳后第8天、第9天或第10天。     

水禽禽流感免疫防控关键技术与措施

如何提高水禽禽流感（AD免疫防控的效果,一直是临床兽医工作者所关注的问题。本文根据“水禽禽流感的免疫防控关键技术研究”所获得的主要成果,从疫苗质量控制、免疫程序制订与实施、免疫效果监测、卫生与饲养管理措施等重要方面陈述了水禽AI防控的技术要点,望对提升水禽AI的防控水平、增加水禽养殖业收益方面有所帮助。     

Research Progress on Livestock and Poultry MHCⅠAntigen Binding Groove

The determination of major histocompatibility complex (MHC) classⅠcomplex structure can elucidate the antigen-binding mechanism,and then effectively utilize the specific CTL response.Currently,several MHCⅠstructures of the livestock and poultry are reported,containing cattle MHCⅠ allele (N*01301,N*01801),pig (SLA-1*0401) and chicken (BF2*2101,BF2*0401,BF2*0201 and BF2*1401).All above MHCⅠstructures are composed of α1,α2,α3 and β₂m chains;And the antigen groove is consisted of six pockets (A,B,C,D,E and F).Generally speaking,how different MHCⅠ binds miscellaneous peptides depends on the B and F pockets.In addition,the MHCⅠsequences have intraspecific and interspecific differences,so the peptides are various for different MHCⅠmolecules.But,different MHCⅠmolecules also can present same peptide,implementing the peptides of cross-presentation.The determination of animal MHCⅠstructures will promote the immunology and vaccine application research.     

畜禽MHCⅠ分子抗原结合槽研究进展

主要组织相容性复合体Ⅰ（major histocompatibility complex, MHCⅠ）结构的解析可直观地阐释其结合抗原表位的机理,进而有效利用其特异性细胞毒性T淋巴细胞（cytotoxic T lymphocyte, CTL）免疫应答。目前已报道的畜禽MHCⅠ精细结构包括牛（N*01301、N*01801）、猪（SLA-1*0401）和鸡（BF2*2101、BF2*0401、BF2*0201、BF2*1401）,以上MHCⅠ复合体结构由α1、α2和α3共3个α链和β₂m组成。其抗原结合槽多肽由A、B、C、D、E、F 6个口袋组成,一般B、F口袋决定了不同MHCⅠ分子结合不同性质的抗原多肽。鉴于同一物种不同的MHCⅠ等位基因及不同物种MHCⅠ基因的序列差异性,使得不同的MHCⅠ分子结合不同性质的抗原多肽片段,此外,不同MHCⅠ分子也可递呈同样的抗原多肽,实现不同MHCⅠ分子的交叉递呈。畜禽MHCⅠ的结构清晰地阐释其递呈抗原多肽的机理,促进了畜禽免疫学和疫苗应用的研究。     

重组SEA增强H5亚型禽流感灭活疫苗对肉鸡的免疫效果研究

为评价重组葡萄球菌肠毒素A(rSEA)对H5亚型禽流感病毒(AIV)灭活疫苗免疫效果的影响,本研究以原核表达的rSEA为免疫增强剂,制备成含有rSEA高(167 μg/0.5 mL)、低(16.7 μg/0.5 mL)两种剂量的AIV油乳剂灭活苗,分别免疫7d龄肉鸡,通过检测免疫鸡AIV HI抗体滴度及外周血CD4+/CD8+值评价其免疫效果.HI 抗体检测结果显示,免疫后2周高剂量组HI抗体平均滴度为5.6 log2,低剂量组为4.2 log2,而无rSEA疫苗对照组为2.9 log2(p＜0.01);同时在免疫后前4周,rSEA免疫组的HI抗体平均滴度及峰值与对照组相比均差异显著(p＜0.05).T淋巴细胞亚群检测结果显示,肉鸡免疫高剂量rSEA的灭活苗后,其外周血CD4+百分含量及CD4+/CD8+值均显著高于对照组(p＜0.05).上述结果表明,rSEA作为AIV灭活苗免疫增强剂,能够快速诱导较高的HI抗体滴度,同时也可增强细胞免疫反应,有效缩短免疫空白期,使肉鸡短时间内产生较强的免疫应答反应.     

禽流感病毒非结构蛋白NS1的分子生物学特性与功能

禽流感严重威胁着世界养禽业及人类健康.随着对流感病毒研究的逐渐深入,人们已经从对流感病毒结构蛋白的研究转移到对非结构蛋白即NS1蛋白的研究上来.研究发现流感病毒的NS1蛋白与流感病毒所诱导的细胞凋亡之间存在一定的联系,其对凋亡的调节作用与流感病毒感染的细胞是否产生干扰素及其所感染的细胞系直接相关.NS1蛋白能够抑制病毒感染细胞干扰素的产生,在流感病毒颉颃干扰素的抗病毒效应中发挥了重要的作用.随着疫苗的广泛使用,无法区分野毒感染和疫苗免疫的禽群,干扰了禽流感的诊断,掩盖了禽流感的流行,增加了禽流感的预防难度.NS1蛋白作为流感病毒的非结构蛋白,具有高度的保守性,在临床应用中作为鉴别诊断免疫禽和自然感染禽的检测抗原具有广阔前景.     

A型流感病毒核衣壳蛋白研究进展

A型流感病毒核衣壳蛋白参与病毒生活周期的多个阶段,影响病毒的转录、复制、装配及转运功能。另外,核衣壳蛋白是细胞毒性T淋巴细胞(CTL)识别的主要抗原,CTL通过识别MHC类分子递呈的核衣壳蛋白抗原肽而清除感染的流感病毒。与核衣壳蛋白有关的CTL免疫逃避的研究证实了CTL反应对于控制病毒感染的重要性。由于核衣壳蛋白诱导产生的细胞免疫反应能针对同型不同亚型的流感病毒株产生交叉反应,将核衣壳蛋白作为疫苗成分有可能提供更加广泛、有效的保护作用。因此,对流感病毒核衣壳蛋白的深入研究,将有利于理解流感的发病机理,并为设计有效的流感疫苗奠定理论基础。     

Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates

Porcine reproductive and respiratory syndrome virus (PRRSV) is an emerging pathogen causing significant economic losses in the swine industry worldwide. Two novel gene-deleted viruses were constructed and evaluated as vaccine candidates. Using the full-length infectious cDNA clone of North American PRRS isolate P129, the ORF2 and ORF4 genes (which encoded minor structural glycoproteins GP2a/2b and GP4, respectively) were individually deleted from the viral genome. Both deletion mutants were non-viable in MARC-145 cells and porcine alveolar macrophages, indicating that both genes are essential for virus replication. To rescue the replication-defective PRRSV, two complementing cell lines, MARC-2000 and MARC-400, were established to stably express the PRRSV GP2 and GP4 proteins, respectively. These cells were able to complement the deleted gene function of PRRSV in trans and supported production of the replication-defective DeltaORF2-PRRSV and DeltaORF4-PRRSV viruses. Both DeltaORF2-PRRSV and DeltaORF4-PRRSV viruses were propagated for 40-50 generations in the corresponding complementing cells and remained replication-defective in MARC-145 cells. To examine the immunogenic potential of the replication-defective PRRSV as vaccine candidates, four groups of pigs, 20 pigs per group, were immunized twice with DeltaORF2-PRRSV or DeltaORF4-PRRSV and challenged with the homologous virulent virus at 3 weeks post-immunization. In spite of the fact one group showed significant reduction in virus load, we could not demonstrate improvement from clinical diseases in this vaccination/challenge study. However, we did show that the cDNA clone of PRRSV can be a useful tool to genetically engineer PRRSV vaccine candidates and to study pathogenesis and viral gene functions.     

Antibody and T cell responses induced in chickens immunized with avian influenza virus N1 and NP DNA vaccine with chicken IL-15 and IL-18

We had examined the immunogenicity of a series of plasmid DNAs which include neuraminidase (NA) and nucleoprotein (NP) genes from avian influenza virus (AIV). The interleukin-15 (IL-15) and interleukin-18 (IL-18) as genetic adjuvants were used for immunization in combination with the N1 and NP AIV genes. In the first trial, 8 groups of chickens were established with 10 specific-pathogen-free (SPF) chickens per group while, in the second trial 7 SPF chickens per group were used. The overall N1 enzyme-linked immunosorbent assay (ELISA) titer in chickens immunized with the pDis/N1 + pDis/IL-15 was higher compared to the chickens immunized with the pDis/N1 and this suggesting that chicken IL-15 could play a role in enhancing the humoral immune response. Besides that, the chickens that were immunized at 14-day-old (Trial 2) showed a higher N1 antibody titer compared to the chickens that were immunized at 1-day-old (Trial 1). Despite the delayed in NP antibody responses, the chickens co-administrated with IL-15 were able to induce earlier and higher antibody response compared to the pDis/NP and pDis/NP + pDis/IL-18 inoculated groups. The pDis/N1 + pDis/IL-15 inoculated chickens also induced higher CD8+ T cells increase than the pDis/N1 group in both trials (P < 0.05). The flow cytometry results from both trials demonstrated that the pDis/N1 + pDis/IL-18 groups were able to induce CD4+ T cells higher than the pDis/N1 group (P < 0.05). Meanwhile, pDis/N1 + pDis/IL-18 group was able to induce CD8+ T cells higher than the pDis/N1 group (P < 0.05) in Trial 2 only. In the present study, pDis/NP was not significant (P > 0.05) in inducing CD4+ and CD8+ T cells when co-administered with the pDis/IL-18 in both trials in comparison to the pDis/NP. Our data suggest that the pDis/N1 + pDis/IL-15 combination has the potential to be used as a DNA vaccine against AIV in chickens.     

Review of DNA Vaccine for Avian Influenza

Avian influenza (AI) is a kind of avian virulent syndrome caused by avian influenza virus (AIV),which threatens animal and human public health and seriously affects the development of poultry industry in China.Vaccination has always been the most effective means to control the spread of avian influenza virus.Based on the continuous development of genetic engineering technology,a variety of new vaccines have been developed and put into use.Among them,avian influenza DNA vaccine has many advantages,such as high safety,simple preparation,easy storage and transportation.Common HA DNA vaccine,NA DNA vaccine,M DNA vaccine,NP DNA vaccine.Avian influenza DNA vaccine introduces a recombinant plasmid containing the target gene sequence into animal cells to induce a humoral and cellular immune response.In order to improve the immune effect of avian influenza DNA vaccine,researchers at home and abroad have made some achievements in enhancing the transfection efficiency and gene expression level of DNA vaccine by adding appropriate adjuvants,introducing target genes into ideal plasmid vectors and optimizing antigen sequence.Since the development of DNA vaccines,many subtypes of avian influenza DNA vaccines,including H1,H3,H5,H7 and H9 subtypes,have been gradually developed.In 2018,the H5 subtype DNA vaccine developed by Harbin Veterinary Research Institute of The Chinese Academy of Agricultural Sciences obtained the National Class Ⅰ Veterinary Medicine certificate,which is the first DNA vaccine of avian influenza to be approved in China,greatly promoting the development of DNA vaccines.This review mainly discusses the development and innovation of avian influenza DNA vaccine in terms of vector construction,immune mechanism,adjuvant and vector selection,and vaccine research and development,and briefly analyzes its application prospect,in order to provide new ideas and references for researchers to develop new avian influenza vaccine.     

禽流感DNA疫苗研究进展

禽流感（avian influenza,AI）是由禽流感病毒（AIV）引起的一种禽类烈性综合征,威胁动物和人类公共健康,严重影响中国养禽业发展,接种疫苗一直是控制禽流感病毒传播最有效的手段。基于基因工程技术的不断发展,各种新型疫苗相继研发并投入使用。其中,禽流感DNA疫苗具有安全性高、制备方法简单、易于储藏和运输等优点,受到了广泛关注。常见的禽流感疫苗有HA DNA疫苗、NA DNA疫苗、M DNA疫苗、NP DNA疫苗等。禽流感DNA疫苗是将含有目的基因序列的重组质粒导入动物细胞,诱导动物机体产生体液和细胞免疫应答。为了提高禽流感DNA疫苗的免疫效果,国内外学者通过添加合适的佐剂、将目的基因导入理想质粒载体、对抗原序列优化,增强DNA疫苗的转染效率和基因表达水平,取得了一定的研究成果。自DNA疫苗开始研发至今,H1、H3、H5、H7、H9等众多亚型禽流感DNA疫苗逐步研发。2018年,由中国农业科学院哈尔滨兽医研究所研制的禽流感H5亚型DNA疫苗获得国家一类新兽药证书,是中国首个获得批准的禽流感DNA疫苗,极大地推动了DNA疫苗的发展。文章主要论述了禽流感DNA疫苗的载体构建、免疫机制、佐剂和载体选择以及疫苗研发等方面的研究进展和创新,并对其应用前景进行简要分析,旨在为科研工作者研制新型禽流感疫苗提供新的思路和参考。     

Antibody detection-based differential ELISA for NDV-infected or vaccinated chickens versus NDV HN-subunit vaccinated chickens

With the advent of subunit vaccines for microbial diseases it is becoming increasingly important to be able to differentiate naturally infected animals from those vaccinated with the corresponding subunit vaccine. For avian viruses such as Newcastle disease virus (NDV), a whole virus-based ELISA cannot make such a differential diagnosis since in both cases the antisera would react with the whole virus. The nucleocapsid protein (NP) gene of the NDV Hitchner B1 strain was cloned, sequenced and expressed to develop a differential ELISA. The B1 NP had 95.7 and 96.1% amino acid identities with the NP of the d26 and Ulster 2C strains, respectively. The B1 NP expressed in a baculovirus expression vector (recNP) was the expected size and reacted with NDV-specific antibodies (Ab) in Western blots and by radioimmunoprecipitation. The ELISA using recNP-coated wells, tested on serum samples from flocks pretested with a commercial NDV kit gave results corresponding to those of the kit. Furthermore, use of both the renNP-based ELISA and a whole virus ELISA allowed the differentiation of birds vaccinated and a NDV haemagglutinin-neuraminidase (HN) expressing fowlpox virus from birds infected with NDV. This provides the basis for establishing an ELISA that discriminates between the antibody response to a recombinant fowlpox vaccine (expressing NDV HN protein) and that to live and inactivated NDV.     

Immunization of chickens with Salmonella enterica subspecies enterica serovar Enteritidis pathogenicity island-2 proteins

Several structural components of the type III secretion systems (T3SS) encoded by Salmonella pathogenicity island (SPI)-1 and SPI-2 are exposed to the host's immune system prior to/during the infection/invasion process, making them potential vaccine candidates. In this study we evaluated whether chickens vaccinated with SPI-2 T3SS components could mount a significant humoral immune response (as measured by serum IgG titres) and whether these antibodies could be transferred to progeny (as measured by egg yolk IgG titres), and whether vaccinates and progeny of vaccinates could be protected against challenge with SE. The results of our studies show that vaccinated chickens do produce high levels of SPI-2 T3SS specific serum IgG that they are able to transfer to their progeny. It was demonstrated that vaccinates and progeny of vaccinates had lower overall countable recovered Salmonella enterica subspecies enterica serovar Enteritidis (SE) per bird in most situations.     

Isolation and characterization of a novel H9N2 influenza virus in Korean native chicken farm

An outbreak of avian influenza, caused by an H9N2 low-pathogenic avian influenza virus (AIV), occurred in a chicken farm and caused severe economic losses due to mortality and diarrhea. AIV was isolated and identified in a sample from an affected native Korean chicken. Genetic analysis of the isolate revealed a high sequence similarity to genes of novel reassortant H9N2 viruses isolated from slaughterhouses and live bird markets in Korea in 2008 and 2009. Animal challenge studies demonstrated that the replication kinetics and pathogenicity of the isolate were considerably altered due to adaptation in chickens. Vaccine protection studies indicated that commercial vaccine was not able to prevent virus shedding and clinical disease when chickens were challenged with the isolate. These results suggest that the novel H9N2 virus possesses the capacity to replicate efficiently in the respiratory system against vaccination and to cause severe disease in domestic chickens. The results also highlight the importance of appropriate updating of vaccine strains, based on continuous surveillance data, to prevent the possibility of a new H9N2 epidemic in Korea.     

Development of enzyme-linked immunosorbent assay with nucleoprotein as antigen for detection of antibodies to avian influenza virus

During the avian influenza outbreak of 2003-04 in Southeast Asia, two avian influenza viruses (AIV), one of H5N1 subtype and the other H9N2 subtype, were isolated and identified from local farms. The nudeoprotein (NP) gene of the H5N1 AI isolate was cloned, and the segment encoding amino acid 47-384, which covers its major antigenic domains, was subcloned and expressed in E. coli. Subsequently, the NP (47-384) expression product was purified and used as the diagnostic antigen to develop a NP-based type-specific indirect enzyme-linked immunosorbent assay (ELISA) for detecting antibodies to AI from chicken sera. The ELISA is shown to be specific for AIV and does not cross-react with chicken sera that has antibodies to other avian viruses. The NP(47-384)-ELISA was compared with a hemagglutination inhibition test and a commercial AIV ELISA kit in evaluating 150 sera samples from experimentally AIV-infected or vaccinated specific-pathogen-free (SPF) chickens. Our NP(47-384)-ELISA was more sensitive than the two tests and showed an 82% agreement ratio with the HI test and an 80.67% agreement ratio with the commercial kit. The NP(47-384)-ELISA and the commercial AIV ELISA were used to evaluate 448 field sera samples from diseased chickens or vaccinated chickens during the 2003-04 AI outbreak in China. The two ELISA tests had a 95% agreement ratio. We conclude that the NP(47-384)-ELISA developed in our laboratory was specific and sensitive and it has great application potential in China's long-term prevention and control of AI.     

Treatment of cattle with DNA-encoded Flt3L and GM-CSF prior to immunization with Theileria parva candidate vaccine antigens induces CD4 and CD8 T cell IFN-γ responses but not CTL responses

Theileria parva antigens recognized by cytotoxic T lymphocytes (CTLs) are prime vaccine candidates against East Coast fever in cattle. A strategy for enhancing induction of parasite-specific T cell responses by increasing recruitment and activation of dendritic cells (DCs) at the immunization site by administration of bovine Flt3L and GM-CSF prior to inoculation with DNA vaccine constructs and MVA boost was evaluated. Analysis of immune responses showed induction of significant T. parva-specific proliferation, and IFN-γ-secreting CD4(+) and CD8(+) T cell responses in immunized cattle. However, antigen-specific CTLs were not detected. Following lethal challenge, 5/12 immunized cattle survived by day 21, whereas all the negative controls had to be euthanized due to severe disease, indicating a protective effect of the vaccine (p<0.05). The study demonstrated the potential of this technology to elicit significant MHC class II and class I restricted IFN-γ-secreting CD4(+) and CD8(+) T cells to defined vaccine candidate antigens in a natural host, but also underscores the need to improve strategies for eliciting protective CTL responses.